These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19805754)

  • 1. Comparing interval breast cancer rates in Norway and North Carolina: results and challenges.
    Hofvind S; Yankaskas BC; Bulliard JL; Klabunde CN; Fracheboud J
    J Med Screen; 2009; 16(3):131-9. PubMed ID: 19805754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and tumor characteristics of breast cancer diagnosed before and after implementation of a population-based screening-program.
    Hofvind S; Sørum R; Thoresen S
    Acta Oncol; 2008; 47(2):225-31. PubMed ID: 17851868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved survival rate for women with interval breast cancer - results from the breast cancer screening programme in Malmö, Sweden 1976-1999.
    Zackrisson S; Janzon L; Manjer J; Andersson I
    J Med Screen; 2007; 14(3):138-43. PubMed ID: 17925086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval breast cancer: is it a different type of breast cancer?
    Raja MA; Hubbard A; Salman AR
    Breast; 2001 Apr; 10(2):100-8. PubMed ID: 14965568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Number and characteristics of breast cancer cases diagnosed in four periods in the screening interval of a biennial population-based screening programme.
    Hofvind S; Bjurstam N; Sørum R; Bjørndal H; Thoresen S; Skaane P
    J Med Screen; 2006; 13(4):192-6. PubMed ID: 17217608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval cancer incidence and episode sensitivity in the Norrbotten Mammography Screening Programme, Sweden.
    Bordás P; Jonsson H; Nyström L; Lenner P
    J Med Screen; 2009; 16(1):39-45. PubMed ID: 19349530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of interval breast cancers after 650,000 negative mammographies in 13 Italian health districts.
    Bucchi L; Ravaioli A; Foca F; Colamartini A; Falcini F; Naldoni C;
    J Med Screen; 2008; 15(1):30-5. PubMed ID: 18416953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in risk of death from breast cancer with season and latitude: sun exposure and breast cancer survival in Norway.
    Porojnicu AC; Lagunova Z; Robsahm TE; Berg JP; Dahlback A; Moan J
    Breast Cancer Res Treat; 2007 May; 102(3):323-8. PubMed ID: 17028983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence and prognostic factors of breast cancer diagnosed within and outside of the organised screening program in the department of Loire-Atlantique (1991-2002)].
    Molinié F; Billon-Delacour S; Allioux C; Blais S; Bercelli P; Lombrail P
    Rev Epidemiol Sante Publique; 2008 Feb; 56(1):41-9. PubMed ID: 18295424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating mean sojourn time and screening sensitivity using questionnaire data on time since previous screening.
    Weedon-Fekjaer H; Lindqvist BH; Vatten LJ; Aalen OO; Tretli S
    J Med Screen; 2008; 15(2):83-90. PubMed ID: 18573776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval cancers in the Dutch breast cancer screening programme.
    Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
    Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the national epidemiological program of breast cancer screening in the Grand Duchy of Luxembourg, 1999-2002].
    Scharpantgen A; Lux C; Wagnon MC; Shannoun F; Schank JM; Back C; Brochmann C; Hansen-Koenig D
    Bull Soc Sci Med Grand Duche Luxemb; 2004; (1):33-9. PubMed ID: 15544001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overuse of mammography during the first round of an organized breast cancer screening programme.
    Chamot E; Charvet A; Perneger TV
    J Eval Clin Pract; 2009 Aug; 15(4):620-5. PubMed ID: 19522725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer screening programme as setting for an adjunct research project: effect on programme attendance.
    Gram IT; Lund E
    J Med Screen; 2008; 15(1):44-5. PubMed ID: 18416955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour size at detection according to different measures of mammographic breast density.
    Nickson C; Kavanagh AM
    J Med Screen; 2009; 16(3):140-6. PubMed ID: 19805755
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interval cancers in the beginning years of the breast cancer screening programme in the Belgian province of Limburg.
    Kellen E; Putte GV; Van Steen A; Cloes E; Lousbergh D; Buntinx F; Van Limbergen E
    Acta Clin Belg; 2008; 63(3):179-84. PubMed ID: 18714848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for breast cancer with MRI: recent experience from the Australian Capital Territory.
    Price J; Chen SW
    J Med Imaging Radiat Oncol; 2009 Feb; 53(1):69-80. PubMed ID: 19453531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Asymptomatic breast cancer in non-participants of the national screening programme in Norway: a confounding factor in evaluation?
    Hoff SR; Klepp O; Hofvind S
    J Med Screen; 2012 Dec; 19(4):177-83. PubMed ID: 23486698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Misclassification of American Indian race in state cancer data among non-federally recognized Indians in North Carolina.
    Yankaskas BC; Knight KL; Fleg A; Rao C
    J Registry Manag; 2009; 36(1):7-11. PubMed ID: 19670692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of self-reported Pap smear history in Norwegian women.
    Klungsøyr O; Nygård M; Skare G; Eriksen T; Nygård JF
    J Med Screen; 2009; 16(2):91-7. PubMed ID: 19564522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.